MarsBars Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is an interesting biotechnology company in the clinical and commercial stages for rare and infectious diseases. Its proprietary platforms, LUNAR for lipid-mediated mRNA delivery and STARR for self-amplifying mRNA technology allowed ARCT to create COVID and influenza vaccines already approved in Japan and with MAA filed in the EU. Also, ARCT is developing game-changing therapies advancing in clinical trials, such as ARCT-810 and ARCT-032 for Ornithin ...